(Date:11/21/2008)...l/ -- Alseres,Pharmaceuticals, Inc. (Nasdaq: AL...securities purchase agreement with Robert Gipson f...mon stock of the Company, together with warrants t...ock at an exercise price of,$1.84 per share, for ...nancing,resulted in total gross proceeds of $1 mi...
(Date:11/21/2008)...- Huifeng Bio-Pharmaceutical,Technology, Inc. (OT...roducer,of plant extracts and pharmaceutical raw ...l and food production, is pleased to announce reco...h periods ended September 30, 2008. , "We a...f 2008, Huifeng has,managed to record both record...
(Date:11/21/2008)...Call/ -- DATATRAK,International, Inc. (Nasdaq: ...,on global eClinical solutions for the clinical tr...artner in Japan, NTT DATA Corporation, has placed ...K eClinical platform into production,for a Japane... first,independently designed clinical trial foll...
(Date:11/21/2008)... Vital Images, Inc.,(Nasdaq: VTAL ), a leading ...oftware, and Toshiba Medical Systems Corporation (...ibution agreement for five years, through December...nt, Toshiba will offer Vital Images, solution,thr...n 50 nations in North and,South America, Europe, ...
Breaking Medicine News(10 mins):Health News:Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 2Health News:Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 3Health News:Huifeng Bio-Pharmaceutical (HFGB) Reports Record Sales and Net Income 2Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 2Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 3Health News:Vital Images and Toshiba Renew Distribution Agreement 2Health News:Vital Images and Toshiba Renew Distribution Agreement 3... British Medical Journal shows that bacteria with ... responsible for ear infections can be used succes... Acute Otitis Media is one of the most common bact...nd is often treated// with large amounts of antibi...
...he University of north Carolina at Chapel Hill, s...onvert genetic instructions into action. The U...ical site on a key enzyme that regulates productio... RNA. When the chemical site is occupied, it marke...
...olecule to the brain reverses Alzheimer-like damag...syndrome, a group of brain cells called the basal ...he brain chemical, acetylcholine, which these neur...involved in learning and memory, results in cognit...
...y teams in Stockholm and Boston, looked at the rel...A (the chemical currently used as a ‘marker’ for p...roteins. It was found that men with prostate ...e PSA test could potentially be picked up by measu...
Other Medicine News:(Date:11/20/2008)...20 The following is bei...ty: , , WHAT: World AIDS Day Audio Media ...mber 25, 2008 , 11:00 a.m. EST , Call-in num... https://cc.readytalk.com/r/1xe41i2yre8rs , ...number of people newly put on treatment worldwide,...
(Date:11/20/2008)...zerland, November 20 Arp...ective Drugs Advisory Committee of the,U.S. Food ...ainst the,approval of intravenous iclaprim, an an...nt of patients with complicated skin and skin stru... by methicillin-resistant Staphylococcus,aureus (...
(Date:11/20/2008)... Nov. 20 Radius Health ("Radius") ...15 million to its second institutional financing r...5 million and the total amount raised since the co...institutional investors participated in the financ...uding MPM Capital, The Wellcome Trust, HealthCare ...
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Chem Rx Corporation Schedules 2008 Annual Meeting Date 28466 1Chem Rx Corporation Schedules 2008 Annual Meeting Date 28466 2New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 1New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 2New regulatory mechanism discovered for cell identify and behavior in forming organs 5688 3Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 1Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 2Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 3Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 4Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non Hodgkins Lymphoma 28459 5Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 8791 1Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements 8791 2...ANCISCO, Calif., April 03, 2007,/PRNewswire-FirstC...updated results from its second multi-center Phase... which evaluated escalating doses,of the immunothe...tory prostate cancer (HRPC). Additional follow-up ...omparable to that,being employed in the company,s ...
...if.--(BUSINESS WIRE)--Apr 3, 2007 - Arrowhead Rese...ication by its,majority-owned subsidiary Calando P...anti-proliferative effect of the siRNA sequence,se...ti-cancer,compound, CALAA-01., The paper, entitled...ase Subunit RRM2 Reduce Cell Proliferation In vitr...
Other Medicine Technology:Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3Standard Deflectable Catheters
The Explorer ST "soft tip" catheter has a proximal shaft with a soft tip. It is available in both a 5F and 6F shaft configuration.
...flectable curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
A-Focus I & II Catheters. A-Focus steerable atrial mapping catheter. Available in 10, 12, 14 and 20 electrode configurations. (Shown with 14 electrodes).
Medicine Products: